Metformin Does Not Predict for Prostate Cancer Diagnosis, Grade, or Volume of Disease After Transperineal Template-guided Mapping Biopsy

Conclusion: Metformin did not impact incidence of prostate cancer diagnosis, Gleason score distribution, or volume of disease. (Source: American Journal of Clinical Oncology)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2v6GFoJ
via IFTTT